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Abstract 
 
The aim of this study was to determine the effect of chitosan and chitosan oligosaccharides (COS), 
prepared by enzymatic hydrolysis with cellulase from Trichoderma reesei, Celluclast® on the growth of 
Bifidobacterium sp. The growth of the two bacteria strains were determined every 12 h for 48 h under 
anaerobic incubation at 37 °C in four MRS media containing lactose, COS, chitosan and inulin. The 
bacteria cell growth in substrate-added medium increased significantly after 48 h of incubation, except 
for the chitosan medium. COS was found to have a similar growth effect on B. bifidum ATCC 11863 
and B. breve ATCC 15700 when compared with inulin and lactose. The pH of medium containing 
COS, inulin and lactose fermented with B. bifidum ATCC 11863 and B. breve ATCC 15700 decreased 
rapidly after 12 h. B. bifidum ATCC 11863 showed the highest specific growth rate at 12 h. The results 
revealed that COS support the growth of probiotic bacteria, thus indicating that COS has the potential 
as new prebiotic source in the functional food industry. 
 
Keywords: Chitosan; cellulase; enzymatic hydrolysis; chitosan oligosaccharides; Bifidobacterium 
species. 
 
 
Introduction 
 
The carbohydrates can be classified according to their molecular size or degree of 
polymerisation (DP) into monosaccharides, oligosaccharides or polysaccharides. IUB-IUPAC 
nomenclature defines oligosaccharides as saccharides containing 3 to 10 sugar moieties. In 
terms of physiological properties, carbohydrates can be classified into digestible and non-
digestible. The non-digestible oligosaccharides (NDOs) are low molecular weight 
carbohydrates of intermediates in nature between simple sugars and polysaccharides. They 
can be obtained by direct extraction from natural sources, or produced by chemical 
processes hydrolysing polysaccharides, or by enzymatic and chemical synthesis from 
disaccharides. The NDOs are known to possess important physicochemical and 
physiological properties that made them as potential candidate as prebiotics (Gibson et al., 
2004; Mussato and Mancilha, 2007; Roberfroid, 2007; Licht et al., 2011). Enrichment of diet 
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with NDOs is believed to improve the gut microecology such as bacterial populations, 
biochemical profiles and physiological effects (Crittenden and Payne, 1996; Voragen, 1998; 
Ziemer and Gibson, 1998; Roberfroid and Slavin, 2000).  
Over the past decade, many food products with prebiotic compounds and probiotic 
microorganisms have been produced (Holzapfel and Schillinger, 2002; Tuohy et al., 2003). 
International Scientific Association for Probiotics and Prebiotics (ISAPP) defines prebiotics as 
selectively fermented, dietary ingredients that result in specific changes in the composition 
and/or activity of the gastrointestinal microbiota, thus conferring benefit(s) upon host health. 
A prebiotic is not hydrolysed in the small intestine and that it is selectively fermented in the 
colon by certain beneficial members of the colonic microbiota (Bifidobacterium and 
Lactobacillus genera). The most common prebiotics are non-digestible oligosaccharides 
(NDOs), such as fructooligosaccharides and inulin. Several studies investigated the prebiotic 
effects of other NDOs, such as xylooligosaccharide, galactooligosaccharide, and 
isomaltooligosaccharide (Roberfroid, 1997; Van Loo et al., 1999; Rabiu et al., 2001; Rycroft 
et al., 2001).  
Generally, the intestinal microbial flora has a major effect on gastrointestinal (GI) 
function and in turn on human health. Probiotics, which usually belong to the Bifidobacterium 
and Lactobacillus genera, are live microbial ingredients that benefit the host health via 
colonisation of the lower intestine (Kolida et al., 2002). Bifidobacterium species exhibit 
several health-promoting effects on the GI tract. For instance, when regularly consumed as 
fermented food products, Bifidobacterium species serve as antimicrobial agents against 
various enteric pathogens, decrease serum cholesterol levels, reduce the incidence of colon 
cancer, and prevent gut disorders (Servin, 2004; Ljungh and Wadström, 2006; Sela et al., 
2008; Cronin et al., 2011; Malaguamera et al., 2012). 
Recently, oligosaccharides obtained from chitosan [chitooligosaccharides (COSs)] and 
low-molecular-weight chitosan have been claimed to also exhibit prebiotic effects (Macchi, 
1996; Lee et al., 2002; Pan et al., 2009). COS are partially hydrolysed product of chitosan, a 
biopolymer composed of β-(1-4)-linked N-acetyl-ᴅ-glucoseamine and deacetylated 
glucoseamine units (Lin et al., 2007).  Interest has been recently focused on their solubility in 
acid-free aqueous media, as opposed to high-molecular-weight chitosan. Furthermore, such 
oligomers have more potential than chitosan as a nutraceutical additive because COSs are 
easily absorbed through the intestine, thus quickly entering the blood flow and eliciting 
systemic biological effects (fermented by the intestinal microflora) in the organism (Chae et 
al., 2005; Fernandes et al., 2008). Lee et al. (2002) reported that COS with DP 2 - 8 have a 
bifidogenic effect at concentrations between 0.1% and 0.5% whereas COS have a growth 
stimulatory effect on L. casei and L. brevis at a concentration of 0.1%. Since these 
oligosaccharides are fully deacetylated, they are not digestible by the intestinal enzymes 
increasing the applicability of COS as prebiotics. Recently, Pan et al. (2009) have 
investigated the ability of 90% deacetylated COS ranged from 3 to 6 to act as prebiotics 
using the mouse model system. The study highlighted the concentrations of bifidobacteria 
and lactobacilli were increased while the concentrations of unfavourable enterococcus and 
Enterobacteriaceae in the caecum of mice were reduced when treated with COS for 14 days. 
As aforementioned, prebiotics should elicit the capability to stimulate the growth of probiotic 
bacteria. The main objective of this study was to evaluate the effect of COS upon the growth 
of Bifidobacterium sp. We also examined the pH changes by Bifidobacterium strains.  
 
 
Materials and Methods 
 
Materials and Organism 
 
Chitosan was purchased from Eastern Global Sdn. Bhd. (Parit Buntar, Perak, Malaysia). 
Fruitafit® Inulin IQ, a commercial prebiotic, was obtained from Sensus (Roosendaal, 
Netherlands). de Man Rogosa Sharp (MRS) agar and broth from Merck, Germany was used 
throughout the study. The strains Bifidobacterium breve ATCC 15700 and Bifidobacterium 
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bifidum ATCC 11863 were purchased from Microbiologics, Inc (St. Cloud, Minnesota, USA). 
These strains were selected because they have potential probiotic properties. 
 
  
Preparation of Samples by Enzymatic Hydrolysis 
 
A total of 3% (w/v) chitosan was completely dissolved in 0.2 M acetate buffer (pH 4.5). The 
solution in the reaction vessel was placed in an incubator shaker (Ecotron: Infors-HT; 
Bottmingen, Switzerland) at 49.8 °C, and 25% (v/w) Celluclast® was added to initiate the 
reaction. After 24 h, the mixture was taken out and boiled for 10 min to stop the enzyme 
reaction. UF membranes with 10 kDa molecular weight cut-off were used to remove the 
enzyme. The filtrates were concentrated to about 1/20 with a rotary evaporator under 
reduced pressure. The precipitates were thoroughly washed with ethanol and then dried 
using a freeze dryer (FreeZone 4.5, Labconco; Kansas City, MO, USA).   
 
 
Chromatography and Mass Spectrometry Condition 
 
The components of COS were analysed by Synapt G2 HDMS Quadrupole Time-of-flight 
(QTOF/MS) Mass Spectrometer (Waters, Milford Massachusetts, USA).  
 
 
Culture and Culture Conditions 
 
The Bifidobacterium stock cultures were maintained at -80 °C in 0.05% L-cysteine MRS 
Broth (Merck, Germany) with 15% (wt/vol) glycerol until further analysis. For the prebiotic 
activity assay, 1 mL frozen glycerol stock cultures (1 × 105 CFU/mL) of B. breve ATCC 15700 
and B. bifidum ATCC 11863 were transferred into 9 mL MRS broth and then incubated 
anaerobically for 48 and 96 h, respectively. Approximately 1 mL of overnight cultures (B. 
breve ATCC 15700 and B. bifidum ATCC 11863) was inoculated into 9 mL of MRS broth with 
the following components: 5% lactose, 5% inulin, 5% COS and 5% chitosan. The media were 
then incubated at 37 °C for 48 h under anaerobic conditions using GasPak anaerocult jar 
with Anaerocult® A sachet. Colony counts were done with 12 h interval until 48 h (Dubey and 
Mistry, 1996). 
 
 
Bacterial Enumeration 
 
Bacterial enumeration was performed in duplicates on MRS agar (Merck, Germany) plates at 
0, 12, 24, 36 and 48 h. The inoculated MRS agar plates were incubated at 37 °C for 48 h in 
an anaerobic condition generated using Anaerocult® A sachet (Fernandes et al., 2012). 
Specific growth rate (k), defined based on doubling rate, is used as a way of measuring how 
fast cells are dividing. This parameter was calculated as follows (Kamaly, 1997); 
  
                         
     121102101 loglog303.2 ttXXhk   
 
where X2 and X1 are the cell or colony counts at times t2 and t1, respectively. 
 
 
Determination of pH 
 
The pH of the sample at every 12 h interval for 48 h was measured with a pH metre PB-11 
(Sartorius, Goettingen, Germany). 
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Statistical Analysis 
 
Differences between specific growth rates were verified by ANOVA using MINITAB14 
software for the pure culture fermentation of Bifidobacterium strains. Differences were 
considered to be statistically significant at p<0.05. 
 
 
Results 
 
Mass Spectrometry Analysis of Hydrolysis Product 
 
Fig. 1 shows the QTOF/MS, which revealed that the products were composed mainly of 
COS, especially DP 3 to 6 (Izume et al., 1992; Aiba, 1994a; Aiba, 1994b).  
 
 
Growth of Bifidobacterium Species Cultivated with Prebiotic Carbohydrates 
 
The cell growth of B. bifidum ATCC 11863 and B. breve ATCC 15700 cultivated in MRS 
broth supplemented with 5% COS, 5% inulin, 5% lactose and 5% chitosan for 48 h at 37 °C 
was measured (Fig. 2). COS was found to have a similar growth effect as lactose and inulin 
on B. bifidum ATCC 11863 and B. breve ATCC 15700. Except for chitosan, the amount of 
cell growth for all test samples significantly increased within 36 h of incubation. After 36 h of 
incubation, the cell growth remained relatively stable until 48 h of cultivation. Decrease of B. 
bifidum ATCC 11863 and B. breve ATCC 15700 survivability in chitosan medium was 
observed after inoculation.  
 
 
Effect of COS on the Specific Growth Rate of Bifidobacterium spp. 
 
The specific growth rates of the Bifidobacterium spp. cultured in MRS supplemented with 
lactose, inulin and COS are summarised in Table 1. The specific growth rates of B. bifidum 
and B. breve in lactose, COS and inulin at 12 h were 0.32 and 0.30 h-1, 0.31 and 0.24 h-1 and 
0.35 and 0.20 h-1, respectively.  
 
 
Changes in pH During Fermentation of COS 
 
The changes in pH of B. bifidum ATCC 11863 and B. breve ATCC 15700 and cultivated in 
MRS supplemented with lactose and prebiotic carbohydrates are presented in Table 2. The 
acid development of lactose, inulin, and COS fermented with B. bifidum ATCC 11863 after 
12 h increased rapidly. The changes in pH (range: 5.16–5.19 to 4.64–4.67) of B. bifidum 
ATCC 11863 cultivated with lactose and inulin were greater than that with COS.  
The pH changes was species-dependent with B. breve ATCC 15700 showed a greater 
reduction in pH than B. bifidum ATCC 11863 (Table 2). The pH changes for B. bifidum ATCC 
11863 in the medium with substrate lactose, COS and inulin showed similar decreasing 
pattern from initial pH (5.16-5.22) to pH (4.64-4.74). pH changes for B. breve ATCC 15700 in 
the medium with substrate lactose, COS and inulin decreased from initial pH (5.15-5.18) to 
pH (4.29-4.55). For chitosan, pH changes from 6.40 to 6.33 and from 6.34 to 6.25 were 
observed for B. breve ATCC 15700 and B. bifidum ATCC 11863, respectively. These values 
remained relatively stable over 36 h of incubation. 
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Figure 1. QTOF/MS of products from hydrolysis of chitosan by cellulase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of chitosan oligosaccharide (COS) on the growth of (A) Bifidobacterium  bifidum 
ATCC 11863 (B) Bifidobacterium breve ATCC 15700  at different cultivation times. Results are given 
as means ± SD of triplicate samples. 
 
 
Discussion 
 
QTOF-MS Analysis of COS 
 
COS was prepared by enzymatic hydrolysis and QTOF/MS showed that the oligomer (2 dp 
to 6 dp) was completely deacetylated (Figure 1). Cellulase can hydrolyse chitosan to yield 
(GlcN)3, (GlcN)4, (GlcN)5, and (GlcN)6. This observation indicates that cellulase can split the 
β-1,4-glycosidic linkages of GlcN–GlcN. Cellulase can also produce (GlcN)2–GlcNAc, 
(GlcN)–(GlcNAc)2, (GlcN)3–GlcNAc, (GlcN)2–(GlcNAc)2, (GlcN)4–GlcNAc, and (GlcN)3-
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(GlcNAc)2. These results suggest that cellulase can selectively cleave GlcNAc–GlcN linkage, 
and that the hydrolysate is a mixture of heterooligomers, each of which carries a GlcNAc 
residue at the reducing end (Kittur et al., 2003).  
 
 
COS Effect upon the Growth of Bifidobacterium sp 
 
It is now well established that the colonic micro flora has a profound influence on health 
(Steer et al., 2000). Consequently, there is currently a great deal of interest in the use of 
prebiotic oligosaccharides as functional food ingredients to manipulate the composition of 
colonic microflora in order to improve health (Gibson and Roberfroid, 1995; Gibson and 
Fuller, 2000; Roberfroid, 2000; Hammes and Hertel, 2002; Losada and Olleros, 2002). 
Prebiotic oligosaccharides stimulate the growth and colonisation of probiotic bacteria, that is, 
non-pathogenic organisms that when ingested are beneficial to health (Rastall and Maitin, 
2002). Therefore, the effectiveness of a prebiotic depends on its ability to be selectively 
fermented by and to support the growth of target organisms. The growth (calculated as log 
CFU/mL) of B. bifidum ATCC 11863 and B. breve ATCC 15700 cultivated with COS showed 
a similar growth effects with lactose and inulin. Except for chitosan, the amount of cell growth 
for all test samples significantly increased within 36 h of incubation. After 0 h of incubation, 
no growth of B. bifidum ATCC 11863 and B. breve ATCC 15700 in chitosan medium was 
observed. The population decreased between 12 and 36 h of incubation. This finding may be 
attributed to the lack of enzymes that are capable of digesting and utilising large chitosan 
molecules (Vernazza et al., 2005). This finding showed that the similar growth on COS, inulin 
and lactose, thus we agree with Huebner et al. (2007) who concluded that for a given sugar 
to have a prebiotic activity, it should be metabolised by a test strain as well as lactose. Lee et 
al. (2002) reported COS has a bifidogenic effect at concentrations between 0.1% and 0.5% 
although intestinal enzymes and lysozymes fully digested deacetylated COS. Moreover, 
COS at a concentration of 0.1% has a growth stimulatory effect on Lactobacillus casei and 
Lactobacillus brevis.  
  
  
Table 1. Specific growth rate of Bifidobacterium species in 5% lactose, 5% chitosan oligosaccharide 
(COS) and 5% inulin 
 
Culture b Medium 
Specific growth rate, k (h-1) a 
0 h 12 h 24 h 
B. bifidum ATCC 11863 Lactose 0.02 cA 0.32 B 0.08 dA 
COS 0.07 dA 0.31 B 0.11 dA 
Inulin 0.07 dA 0.35 B 0.03 cA 
B. breve ATCC 15700 Lactose 0.02 cA 0.30 cB 0.04 cA 
COS 0.13 eB 0.24 dC 0.02 cA 
Inulin 0.08 dA 0.20 dB 0.07 dA 
 
a Values represent averages of triplicates experiments. 
b Initial cell population of B. bifidum ATCC 11863 and B. breve ATCC 15700 was approximately 1 × 105 CFU/mL. 
c-e Data in the same column with different lowercase letter is different significantly (p<0.05). 
A-C Data in the same row with different uppercase letter is different significantly (p<0.05).  
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When comparing the two strains of Bifidobacterium species, the cell growth of B. breve 
ATCC 15700 was higher than that of B. bifidum ATCC 11863 under the same conditions (48 
h, 37 °C) and inoculum amount (105 CFU/mL). The slow growing strain Bifidobacterium 
bifidum var pennysylvanicus (ATCC 11863) was found to have a high N-acetyl-D-
glucosamidase activity. This organism, isolated from the stools of breast-fed and bottle-fed 
infants, require N-acetyl-D-glucosamine-containing saccharides as substrates for cell wall 
synthesis (Poupard et al., 1973). The differences in growth rates among the species of 
Bifidobacterium might be also explained by their different levels of tolerance to aerobic 
conditions. Obligate anaerobic species might have grown poorly because of the insufficient 
oxidation-reduction potential of the medium. The growth of anaerobic organisms might be 
stimulated by the addition of L-cysteine to decrease the oxidation-reduction potential of the 
medium. The inoculum was grown in MRS supplemented with yeast extract and L-cysteine 
(Desjardins et al., 1990). 
From the findings, at 12 h the growth rate of B. bifidum ATCC 11863 and B. breve 
ATCC 15700  in lactose was higher than that in COS and inulin, with a significant difference 
(p<0.05) at 24 h of fermentation (Table 1). In other incubation periods, there were significant 
differences (P<0.05) in growth rate between the strains cultured in COS, lactose and inulin 
although COS tended to show the highest specific growth rate for B. bifidum ATCC 11863. 
The growth rate of the strains in COS and inulin for different times differ significantly 
(p<0.05).  When comparing the growth rate for different times (horizontal comparison), the 
increase in the growth rate of B. bifidum ATCC 11863 cultured in inulin was significantly 
higher (p<0.05) than that in lactose and COS. The growth rates of the B. bifidum ATCC 
11863 and B. breve ATCC 15700 in COS and lactose differ significantly (p<0.05) after 0 h to 
24 h of fermentation, the trend of the growth is the same as that in inulin. These results 
indicate that the growth rate of B. bifidum ATCC 11863 and B. breve ATCC 15700 in COS is 
similar to that in inulin and lactose. Therefore, COS could be used as a sole carbon source 
for the growth of the human gut microflora. 
The decrease in pH was dependent on the species. B. breve ATCC 15700 showed a 
greater decrease in pH than B. bifidum ATCC 11863. This finding may be attributed to the 
fact that Bifidobacterium species produce 3 mol acetic acid and 2 mol lactic acid for each two 
mol glucose (Scardovi, 1986). The production of these two organic acids and low pH values 
in the colon are among the probiotic factors contributing to the well-being of the host in which 
they will suppress the growth of unwanted microorganisms in the gut (Crittenden, 1999). 
Scardovi (1986) stated that Bifidobacterium species have a narrow optimum pH range (6.5 to 
7) for growth and that no growth occurs at pH <5 or >8. Desjardins et al. (1990) revealed that 
most Bifidobacterium strains demonstrate a relationship between growth rate and acid 
production. This finding is consistent with the results of the present study.  
 
 
Conclusion 
 
This study investigated the effects of chitosan and its oligosaccharides on the growth of B. 
bifidum ATCC 11863 and B. breve ATCC 15700. The amount of cell growth for all medium 
samples, except for the chitosan medium, significantly increased within 48 h of incubation. 
COS was found to have a similar effect on B. bifidum ATCC 11863 and B. breve ATCC 
15700 with inulin and lactose. The pH changes of COS, inulin and lactose fermented with B. 
bifidum ATCC 11863 and B. breve ATCC 15700 after 12 h increased rapidly. The specific 
growth rate of bifidobacterium species was higher at 12 h and B. bifidum ATCC 11863 
showed the highest specific growth rate. Observation of both strains demonstrated that a 
relationship exists between growth rate and acid production. 
The study has shown prospects for COS as a functional food, a prebiotic in promoting 
the growth of bifidobacteria. Thus further investigation of the full range of chitosan molecules 
reaching the gut should thus be undertaken to verify the safety of these molecules.  
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